STOCKHOLDERS' EQUITY - Incentive Plans (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Jan. 29, 2020
Number of Shares
Outstanding at the end of the period (in shares)	132,822
Weighted Average Exercise Price Per Share
Outstanding at the end of the period (in dollars per share)	$ 28.32
Weighted Average Remaining Contractual Term
Options exercisable	0	0
Outstanding at the end of the period	3 years 1 month 6 days
Number of Shares
Unvested outstanding shares at the beginning of the period (in shares)	889,394	775,515
Granted (in shares)	30,000	225,700
Vested (in shares)	(158,845)	(98,121)
Forfeited (in shares)	(509,013)	(13,700)
Unvested outstanding shares at the end of the period (in shares)	251,536	889,394
Weighted Average Grant Date fair Value Per Share
Unvested outstanding shares at the beginning of the period (in dollars per share)	$ 10.03	$ 9.16
Granted (in dollars per share)	10.68	13.75
Vested (in dollars per share)	12.48	11.40
Forfeited (in dollars per share)	9.04	12.20
Unvested outstanding shares at the end of the period (in dollars per share)	$ 10.56	$ 10.03
Aggregate Intrinsic Value
Aggregate Intrinsic Value at the beginning of the period (in dollars)	$ 3,993	$ 2,914
Aggregate Intrinsic Value at the end of period (in dollars)	1,141	3,993
General and administrative
Stock-based compensation
Compensation expense recorded	$ 1,100	$ 2,200
2020 Incentive Plan | Common Stock
Stock-based compensation
Aggregate number of shares available			1,800,000
Maximum number of shares that remained reserved for issuance under the Plan	1,100,000
2020 Incentive Plan | Restricted Stock
Additional Disclosures
Total fair value of shares vested	$ 1,500